Chimerix, Inc.

Chimerix, Inc.verified

CMRX

Price:

$8.54

Market Cap:

$801.08M

Chimerix, Inc. operates as a biopharmaceutical company, committed to advancing therapeutic solutions that improve the lives of individuals grappling with severe medical conditions. Its sole approved medicine is TEMBEXA (brincidofovir), a lipid conjugate designed to combat smallpox by inhibiting viral DNA synthesis, positioned as a critical medical countermeasure. Beyond its commercial offering, Chimerix boasts a robust clinical-stage pipeline: ONC201 targets recurrent diffuse midline glioma in patients whose tumors possess the H3 K27M mutation. ONC206, an imipridone, is a Phase I candidate for solid tumors, functioning as both a Dopamine Receptor D2 (DRD2) antagonist and a caseinolytic prote...[Read more]

Industry

Biotechnology

IPO Date

2013-04-11

Stock Exchange

NASDAQ

Ticker

CMRX

The PE Ratio as of June 2026 (TTM) for Chimerix, Inc. (CMRX) is -8.63

According to Chimerix, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -8.63. This represents a change of 443.78% compared to the average of -1.59 of the last 4 quarters.

Chimerix, Inc. (CMRX) Historical PE Ratio (quarterly & annually)

How has CMRX PE Ratio performed in the past?

The mean historical PE Ratio of Chimerix, Inc. over the last ten years is -2.45. The current -8.63 PE Ratio has changed 35.06% with respect to the historical average. Over the past ten years (40 quarters), CMRX's PE Ratio was at its highest in in the September 2022 quarter at 0.18. The PE Ratio was at its lowest in in the June 2015 quarter at -19.59.

Quarterly (TTM)
Annual

Average

-2.45

Median

-2.46

Minimum

-7.13

Maximum

0.95

Chimerix, Inc. (CMRX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Chimerix, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 998.87%

Maximum Annual PE Ratio = 0.95

Minimum Annual Increase = -209.82%

Minimum Annual PE Ratio = -7.13

Quarterly (TTM)
Annual
YearPE RatioChange
2024-3.53239.97%
2023-1.04-209.82%
20220.95-144.31%
2021-2.13-70.06%
2020-7.13998.87%
2019-0.65-63.91%
2018-1.80-41.32%
2017-3.069.95%
2016-2.79-16.73%
2015-3.35-85.06%

Chimerix, Inc. (CMRX) Average PE Ratio

How has CMRX PE Ratio performed in the past?

The current PE Ratio of Chimerix, Inc. (CMRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-1.21

5-year avg

-2.58

10-year avg

-2.45

Chimerix, Inc. (CMRX) PE Ratio vs. Peers

How is CMRX’s PE Ratio compared to its peers?

Chimerix, Inc.’s PE Ratio is less than Avid Bioservices, Inc. (-5.61), less than Icosavax, Inc. (-6.88), less than Intercept Pharmaceuticals, Inc. (5.58), less than ASLAN Pharmaceuticals Limited (-0.06), less than Harpoon Therapeutics, Inc. (-1.14), less than Albireo Pharma, Inc. (-5.61), less than Ikena Oncology, Inc. (-1.40), less than Poseida Therapeutics, Inc. (-6.94), less than Gracell Biotechnologies Inc. (-1.54), greater than Verve Therapeutics, Inc. (-12.19),

Build a custom stock screener for Chimerix, Inc. (CMRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chimerix, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Chimerix, Inc. (CMRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Chimerix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Chimerix, Inc.'s PE Ratio?

How is the PE Ratio calculated for Chimerix, Inc. (CMRX)?

What is the highest PE Ratio for Chimerix, Inc. (CMRX)?

What is the 3-year average PE Ratio for Chimerix, Inc. (CMRX)?

What is the 5-year average PE Ratio for Chimerix, Inc. (CMRX)?

How does the current PE Ratio for Chimerix, Inc. (CMRX) compare to its historical average?